Pharming Group N.V.
PHAR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828316
No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 16
- 13F valueReported value at the end of Q2 2026
- $1.31M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PHAR, Q2 2026
No superinvestor reported holding PHAR at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Pharming Group N.V. insiders from Form 4, newest first.
No open-market purchases or sales by Pharming Group N.V. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Pharming Group N.V. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Silverberg Bernstein Capital Management LLC | 41,547 | $577.1K | 0.22% | −3,200−7.2% | Reduced |
| Crossmark Global Holdings, Inc. | 12,463 | $169.0K | 0.00% | +12,463 | New |
| Citadel Advisors LLC | 11,972 | $162.3K | 0.00% | +1,783+17.5% | Added |
| Morgan Stanley | 11,500 | $159.7K | 0.00% | +11+0.1% | Added |
| SmartHarvest Portfolios, LLC | 10,415 | $144.7K | 0.05% | −382−3.5% | Reduced |
| Knoll Capital Management, LLC | 4,091 | $56.8K | 0.03% | +34+0.8% | Added |
| Silver Grove Financial Group, Inc. | 1,071 | $14.9K | 0.01% | +1,071 | New |
| Nalls Sherbakoff Group, LLC | 870 | $12.1K | 0.01% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 456 | $6.33K | 0.00% | +456 | New |
| BNP Paribas Arbitrage, SA | 300 | $4.17K | 0.00% | −100−25.0% | Reduced |